Puji B S Asih is an expert in Infectiology at National Agency for Promotion of Research and Innovation (Tunisia). Puji B S Asih has authored 100 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 242 (community average: 125). How the SLR is computed.

LeadR Profile

242 ScienceLeadR Reputation 242
Network Map

Infectiology

Subspecialties: Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026

Source: PubMed

National Agency for Promotion of Research and Innovation

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 100

Citations

Citations: 2 573 1st author: 10 Last author: 11 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Intraspecies genetic diversity and host-associated distribution of Endolimax nana in Sumba Island, Indonesia.
PMID 42629601 — genetic variation, genes, genes, rrna
Trop Med Health20260
Optimal control and cost-effectiveness analysis of PfSPZ vaccination and indoor residual spraying in malaria transmission: a case study in Keerom.
PMID 42459453 — malaria, reproduction, vaccines, incidence, public health, basic reproduction number, vaccination
Front Public Health20260
The Impact of pfmdr1 Gene Copy Number on the Efficacy of Dihydroartemisinin-Piperaquine in Treating Malaria in West Sumba and Kupang Districts, East Nusa Tenggara, Indonesia.
PMID 42180140 — genes, malaria, pharmaceutical preparations, therapeutics, genetic markers, drug resistance, gene dosage
J Parasitol Res20260
Characterization of entomological drivers of malaria transmission in five villages, Keerom Regency, Papua, Indonesia.
PMID 42378257 — malaria, surveys and questionnaires, behavior observation techniques
PLoS One20260
Evaluation of an -expressed spike protein-based in-house ELISA system for assessment of antibody responses after COVID-19 infection and vaccination.
PMID 40352206 — antibody formation, vaccines, enzyme-linked immunosorbent assay, vaccination, covid-19, pandemics, infections
Narra J20251

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 4 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map